PB2258: PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS.

Detalles Bibliográficos
Autores principales: Doddihal, Harsha, Marron, Thomas, C T, Satheesh, Avaronnan, Manuprasad, Nagarkar, Rajnish, Gupta, Vineet Govinda, Benjamin, Biju, Gowda, Nagaraj, Udupa, Venkatesha, Biswas, Nilanjana, Kadam, Jatin, Dhage, Priyanka, Beltran, Adam, Amin, Nikhil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429257/
http://dx.doi.org/10.1097/01.HS9.0000975764.56696.bb

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429257/
http://dx.doi.org/10.1097/01.HS9.0000975764.56696.bb

Ejemplares similares